Announcement on Voluntary Disclosure of Subsidiary’s YKYY025 Injection Obtaining Clinical Trial Approval from the National Medical Products Administration

About this update from Youcare Pharmaceutical Group Co. Ltd. Class A

Announcement on Voluntary Disclosure of Subsidiary’s YKYY025 Injection Obtaining Clinical Trial Approval from the National Medical Products Administration The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Youcare Pharmaceutical Group Co. Ltd. Class A